{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:09:06Z","timestamp":1788480546111,"version":"build-2803163510"},"reference-count":94,"publisher":"Korean Endocrine Society","issue":"5","license":[{"start":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:00:00Z","timestamp":1761696000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2018R1A5A2024425"],"award-info":[{"award-number":["2018R1A5A2024425"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006107","name":"Gachon University Gil Medical Center","doi-asserted-by":"publisher","award":["FRD2023-09-02"],"award-info":[{"award-number":["FRD2023-09-02"]}],"id":[{"id":"10.13039\/501100006107","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["e-enm.org"],"crossmark-restriction":true},"short-container-title":["Endocrinol Metab"],"published-print":{"date-parts":[[2025,10,31]]},"abstract":"<jats:p>Dyslipidemia remains a central modifiable risk factor for atherosclerotic cardiovascular disease (ASCVD). While 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors, commonly known as statins, as well as ezetimibe, fibrates, and omega-3 fatty acids have established roles in lipid lowering, significant residual risk persists in many patients due to insufficient low-density lipoprotein cholesterol (LDL-C) reduction, elevated triglyceride-rich lipoproteins, and genetically determined elevations of lipoprotein(a) (Lp(a)). Recent years have witnessed remarkable advances in therapeutic modalities, including next-generation small molecules, monoclonal antibodies, protein-based infusions, and ribonucleic acid (RNA)\u2013based strategies. These agents target diverse pathways such as proprotein convertase subtilisin\/kexin type 9 (PCSK9), angiopoietin-like protein 3 (ANGPTL3), apolipoprotein C-III, apolipoprotein B, cholesteryl ester transfer protein (CETP), and Lp(a), achieving potent lipid modulation with improved convenience and safety. Clinical outcome trials have validated bempedoic acid, PCSK9 inhibitors, and icosapent ethyl, while large-scale programs are ongoing for obicetrapib, oral PCSK9 inhibitors, Lp(a)-targeted oligonucleotides, and ANGPTL3-directed RNA therapeutics. This review summarizes the mechanisms, pivotal trials, and clinical implications of innovative lipid-lowering therapies, highlighting how they may reshape future treatment algorithms for ASCVD prevention.<\/jats:p>","DOI":"10.3803\/enm.2025.2691","type":"journal-article","created":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T07:54:33Z","timestamp":1761810873000},"page":"668-686","update-policy":"https:\/\/doi.org\/10.3803\/crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Innovative Lipid-Lowering Strategies: RNA-Based, Small Molecule, and Protein-Based Therapies"],"prefix":"10.3803","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8802-268X","authenticated-orcid":true,"given":"Youngwoo","family":"Jang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6108-7758","authenticated-orcid":true,"given":"Eun-Jung","family":"Rhee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0740-8116","authenticated-orcid":true,"given":"Sung Hee","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2119","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.4093\/dmj.2022.0295"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3803\/enm.2022.402"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.4244\/eij-d-25-00331"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/medicina61101730"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-87868-x"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-024-02862-5"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.4093\/dmj.2021.0183"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.4093\/dmj.2022.0363"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.4093\/dmj.2022.0443"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3803\/enm.2023.102"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3803\/enm.2023.1809"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3803\/enm.2023.1857"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3803\/enm.2021.1046"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3803\/enm.2023.1770"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00043"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-019-1158-5"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1253\/circj.cj-20-1037"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvab199"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1253\/circj.cj-20-0051"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.54912\/jci.2024.0014"},{"key":"ref21","first-page":"1383","volume-title":"Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)","year":"1994"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(02)09327-3"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa050461"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2008.12.037"},{"key":"ref25","first-page":"2387","volume-title":"Ezetimibe added to statin therapy after acute coronary syndromes","author":"Cannon","year":"2015"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(05)67667-2"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1001282"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1111\/dom.13686"},{"key":"ref29","first-page":"1923","volume-title":"Triglyceride lowering with pemafibrate to reduce cardiovascular risk","author":"Das Pradhan","year":"2022"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1107579"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1300955"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1812792"},{"key":"ref33","first-page":"2268","volume-title":"Effect of high-dose omega-3 fatty acids vs corn oil on major adverse cardiovascular events in patients at high cardiovascular risk: the strength randomized clinical trial","author":"Nicholls","year":"2020"},{"key":"ref34","first-page":"1353","volume-title":"Bempedoic acid and cardiovascular outcomes in statin-intolerant patients","author":"Nissen","year":"2023"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1206797"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2017.08.007"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2415820"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2024.05.002"},{"key":"ref39","first-page":"1996","volume-title":"An oral PCSK9 inhibitor for treatment of hypercholesterolemia: the PURSUIT randomized trial","author":"Koren","year":"2025"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(12)61731-0"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.r026658"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa054013"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1038\/ng1161"},{"key":"ref44","first-page":"1552","volume-title":"Effect of naturally random allocation to lower low-density lipoprotein cholesterol on the risk of coronary heart disease mediated by polymorphisms in NPC1L1, HMGCR, or both: a 2 \u00d7 2 factorial Mendelian randomization study","author":"Ference","year":"2015"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1172\/jci29383"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(14)61399-4"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1105803"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1701488"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.4161\/mabs.2.3.11641"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1007\/s00253-016-7388-9"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2023.11.029"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1615664"},{"key":"ref53","first-page":"2097","volume-title":"Alirocumab and cardiovascular outcomes after acute coronary syndrome","author":"Schwartz","year":"2018"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2022.03.002"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehx002"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1161\/jaha.121.023328"},{"key":"ref57","first-page":"211","volume-title":"Genetic and pharmacologic inactivation of ANGPTL3 and cardiovascular disease","author":"Dewey","year":"2017"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1161\/atvbaha.120.315204"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2004215"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1172\/jci109956"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1161\/atvbaha.108.179283"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1038\/ncpcardio0661"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1001\/jama.290.17.2292"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2018.2112"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.116.025687"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2400969"},{"key":"ref67","first-page":"5023","volume-title":"Apolipoprotein A-I infusions and cardiovascular outcomes in acute myocardial infarction according to baseline LDL-cholesterol levels: the AEGIS-II trial","author":"Gibson","year":"2024"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2018.2121"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-022-01649-3"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.12997\/jla.2022.11.3.250"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2016.12.003"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1007\/s11883-023-01156-5"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.3909\/ricm19s1s0002"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-021-01473-6"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehac594"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1016\/s2213-8587(22)00353-9"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2022.0987"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1007\/s40256-021-00499-1"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1905239"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2415818"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2024.21957"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.1080\/14779072.2020.1768848"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1715944"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.1016\/s2213-8587(21)00046-2"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab820"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2400201"},{"key":"ref87","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2024.0959"},{"key":"ref88","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2404143"},{"key":"ref89","first-page":"127","volume-title":"Plozasiran for managing persistent chylomicronemia and pancreatitis risk","author":"Watts","year":"2025"},{"key":"ref90","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2404147"},{"key":"ref91","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.124.068885"},{"key":"ref92","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2018.1550071"},{"key":"ref93","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-019-01114-z"},{"key":"ref94","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvae109"}],"container-title":["Endocrinology and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.e-enm.org\/upload\/pdf\/enm-2025-2691.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.e-enm.org\/journal\/view.php?doi=10.3803\/EnM.2025.2691","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.e-enm.org\/upload\/pdf\/enm-2025-2691.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T06:53:24Z","timestamp":1762412004000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.e-enm.org\/journal\/view.php?doi=10.3803\/EnM.2025.2691"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,31]]},"references-count":94,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,10]]}},"URL":"https:\/\/doi.org\/10.3803\/enm.2025.2691","relation":{},"ISSN":["2093-596X","2093-5978"],"issn-type":[{"value":"2093-596X","type":"print"},{"value":"2093-5978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,31]]},"assertion":[{"value":"2025-09-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-20","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-29","order":2,"name":"published","label":"Published online","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-31","order":3,"name":"published","label":"Print publication","group":{"name":"publication_history","label":"Publication History"}}]}}